Clinical Trials
29 trialsPINNACLE
Spectrum Pharmaceuticals, Inc
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
National Cancer Institute (NCI)
LoTam
Alliance for Clinical Trials in Oncology
Assessment of Early Radiation Oncology Involvement Alongside Standard Oncologic Care in the Managemet
Rutgers, The State University of New Jersey
MATCH
University of Texas Southwestern Medical Center
IPT
New York State Psychiatric Institute
Eribulin Mesylate or Paclitaxel as First- or Second-Line Therapy in Treating Patients With Recurrent Stage IIIC-IV Breast Cancer
Academic and Community Cancer Research United
68Ga-PSMA PET/CT in Prostate Cancer
University of Saskatchewan
Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma
Precision Life Sciences Group
DIRECT-2
Leiden University Medical Center
A Trial Evaluating the Efficacy and Safety of EndoTAG®-1 in Combination With Paclitaxel and Gemcitabine Compared With Paclitaxel and Gemcitabine as First-line Therapy in Patients With Visceral Metastatic Triple-negative Breast Cancer
SynCore Biotechnology Co., Ltd.
PSSR
Zhejiang University
SERENITY
Tetra Bio-Pharma
Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer
University of Rome Tor Vergata
HCC
Sun Yat-sen University
A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
CARACO
Institut Cancerologie de l'Ouest
Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+
Ruijin Hospital
Lovenox
National Guard Health Affairs
Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma
Shanghai Jiao Tong University School of Medicine
GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
Combination Chemotherapy in Treating Women With Stage III Breast Cancer
National Cancer Institute (NCI)
Liposomal Cytarabine for Central Nervous System (CNS)-Treatment in High-risk Acute Lymphoblastic Leukemia (ALL)
Nordic Society for Pediatric Hematology and Oncology
CARPAN
University Medicine Greifswald
Randomized Phase III Trial of Surgery Alone or Surgery Plus Preoperative Gemcitabine-Cisplatin in Clinical Early Stages of Non-small Cell Lung Cancer
King Faisal Specialist Hospital & Research Center
Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery
OMRIX Biopharmaceuticals
HOSTT
Tri-Service General Hospital
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients
Medical University of Gdansk